FDA

Week in Review

Week in Review

Supreme Court will not hear tobacco labeling case, Administration releases new drug policy, and more.

Week in Review

Week in Review

FTC cracks down on cell phone cramming, gun control bill hits wall in Senate, and more.

Protecting Children from Bioterrorism and Biomedical Research

Protecting Children from Bioterrorism and Biomedical Research

Bioethics Commission weighs in on ethical ways to test anthrax vaccines on children.

Week in Review

Week in Review

FHFA proposes alternative to Fannie and Freddie, TSA to allow pocket knives onto planes, and more.

FDA Convenes Public Meeting on Proposed Food Safety Rules

FDA Convenes Public Meeting on Proposed Food Safety Rules

Industry lobbyists and safety advocates testify to the benefits and burdens of two major proposed rules.

Week in Review

Week in Review

HHS implements provisions of the ACA, CFPB and FDIC reportedly investigate online payday lending, and more.

Week in Review

Week in Review

DOJ reviews gun safety technology, FCC proposes rule to free up government airwaves, and more.

Will OMB Make the Right Decision on Menu Labeling?

Will OMB Make the Right Decision on Menu Labeling?

Requiring grocery stores to display calories may be too costly for its purported benefits.

Week in Review

Week in Review

HHS issues rule affecting doctor payments, judge accepts Transocean guilty plea, and more.

Improving Drug Safety Regulation after the Meningitis Outbreak

Improving Drug Safety Regulation after the Meningitis Outbreak

Congress should provide FDA with clearer authority and increased resources.

Regulatory Breakdown in the United States

Regulatory Breakdown in the United States

The Regulatory Review summarizes the work of leading scholars from the newly published book Regulatory Breakdown: The Crisis of Confidence in U.S. Regulation.

A Prescription for the FDA

A Prescription for the FDA

To solve fundamental problems, food and drug safety agency must adapt.